Precision Oncology Market: By Type (Consumable, Instruments, Services), By End User (Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, CROs) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Precision Oncology Market size was valued at USD 49.5 billion in 2022. It is expected to reach a value of USD 96.5 billion by 2029, growing at a CAGR of 10.1% from 2023 to 2029. Precision oncology is a cutting-edge kind of cancer therapy that makes sure your care is tailored to your particular type of cancer. It is the science of harnessing the unique genetics of each patient the genes that are mutated and cause their disease to spread to develop a personalized treatment plan based on those genetic mutations.

The global market provides a detailed overview of the market, which has been segmented by type and end-user. By type, the precision oncology market has been segmented into consumable Instruments and Services. The Consumable segment is likely to be the largest and fastest-growing in terms of type. Precision oncology is segmented into Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, and CROs based on the end-user. According to precision business insights, the Diagnostic Companies segment is predicted to register the fastest growth rate during the forecast period.

Precision Oncology Market Key Development:
  • In July 2019, Pfizer collaborated with Syapse to advance cancer research. This collaboration was aimed to focus on molecular testing and therapy choices in precision oncology, thereby expanding the product portfolio.

Precision Oncology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10.1%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Precision Oncology Market Dynamics

Precision medicine combines molecular biology and system biology and is a new cancer treatment and prevention approach. Oncology precision medicine has emerged as potentially transformational, promising more excellent treatment outcomes for all cancer patients.

Key Features of the Reports

  • The precision oncology market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The precision oncology market report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The precision oncology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The precision oncology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The precision oncology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Precision Oncology Market Segmentation

By Type
  • Consumable,
  • Instruments,
  • Services
By end user
  • Pharmaceuticals Companies,
  • Biotechnology Companies,
  • Diagnostic Companies,
  • CROs
By Geography
  • North America,
  • Europe,
  • Asia Pacific,
  • Latin America and
  • Middle East and Africa

Frequently Asked Questions

The precision oncology market is projected to expand at a CAGR of 10.1% during the forecast period.

The major global precision oncology market players are ??? Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc., NeoGenomics, QIAGEN, and Tepnel Pharma Services.

North America is the fastest-growing region for  precision oncology market

1. Executive Summary
2. Global Precision Oncology Market Introduction
2.1. Global Precision Oncology Market Taxonomy
2.2. Global Precision Oncology Market Definitions
2.2.1. By End-user
2.2.2. By Type
3. Global Precision Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Precision Oncology Market Dynamic Factors - Impact Analysis
3.6. Global Precision Oncology Market Competition Landscape
4. Global Precision Oncology Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Precision Oncology Market, By End-user, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Pharmaceuticals Companies
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Biotechnology Companies
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Diagnostic Companies
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. CROs
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Precision Oncology Market Forecast, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Consumable
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Instruments
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Precision Oncology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Region, 2023 - 2029
8. North America Precision OncologyMarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Pharmaceuticals Companies
8.1.2. Biotechnology Companies
8.1.3. Diagnostic Companies
8.1.4. CROs
8.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Consumable
8.2.2. Instruments
8.2.3. Services
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country, 2023 - 2029
8.5. North America Precision Oncology Market Dynamics Trends
9. Europe Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Pharmaceuticals Companies
9.1.2. Biotechnology Companies
9.1.3. Diagnostic Companies
9.1.4. CROs
9.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Consumable
9.2.2. Instruments
9.2.3. Services
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029
9.5. Europe Precision Oncology Market Dynamics Trends
10. Asia-Pacific Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Pharmaceuticals Companies
10.1.2. Biotechnology Companies
10.1.3. Diagnostic Companies
10.1.4. CROs
10.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Consumable
10.2.2. Instruments
10.2.3. Services
10.3. Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029
10.5. Asia-Pacific Precision Oncology Market Dynamics Trends
11. Latin America Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Pharmaceuticals Companies
11.1.2. Biotechnology Companies
11.1.3. Diagnostic Companies
11.1.4. CROs
11.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Consumable
11.2.2. Instruments
11.2.3. Services
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029
11.5. Latin America Precision Oncology Market Dynamics Trends
12. Middle East and Africa Precision Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. End-user Analysis 2018 - 2022 and Forecast 2023 - 2029by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Pharmaceuticals Companies
12.1.2. Biotechnology Companies
12.1.3. Diagnostic Companies
12.1.4. CROs
12.2. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Consumable
12.2.2. Instruments
12.2.3. Services
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2023 - 2029
12.5. MEA Precision Oncology Market Dynamics Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Eagle Genomics
13.2.2. ASEBIO
13.2.3. Menarini Silicon Biosystems
13.2.4. NanoString Technologies, Inc.
13.2.5. NeoGenomics
13.2.6. QIAGEN
13.2.7. Tepnel Pharma Services
14. Research Methodology
15. Key Assumptions and Acronyms
  • Eagle Genomics
  • ASEBIO
  • Menarini Silicon Biosystems
  • NanoString Technologies, Inc.
  • NeoGenomics
  • QIAGEN
  • Tepnel Pharma Services